Executive Summary
Interview with Daniel Malek, CEO of NEXTHERA Capital, a New York based fundamental long/short equity strategy concentrating in the global healthcare sector with a focus on therapeutics and selected by RJ Management investment team.
Healthcare & Biotech Chat With Daniel Malek, CEO of NEXTHERA Capital
13.07.2018